Laura Huppert, MD, BA
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| ARX788 for Treating Patients With HER2-low Locally Advanced Unresectable or Metastatic Breast Cancer (NCT06224673) | Laura Huppert, MD, BA | 2026-06-05 |
| Avelumab With Binimetinib, Sacituzumab Govitecan, or Liposomal Doxorubicin in Treating Stage IV or Unresectable, Recurrent Triple Negative Breast Cancer (NCT03971409) | Laura Huppert, MD, BA | 2019-07-08 |
| Pembrolizumab With Carboplatin Compared to Carboplatin Alone in Breast Cancer Patients With Chest Wall Disease (NCT03095352) | Laura Huppert, MD, BA | 2017-09-02 |
Track Laura Huppert, MD, BA automatically
Every clearance here is in the API, with alerts when new ones post.